title: Macrophage activation syndrome after etanercept treatment.
authors.forename: Charanjit
authors.initials: C
authors.lastname: Sandhu
authors.forename: Alden
authors.initials: A
authors.lastname: Chesney
authors.forename: Eugenia
authors.initials: E
authors.lastname: Piliotis
authors.forename: Rena
authors.initials: R
authors.lastname: Buckstein
authors.forename: Sharon
authors.initials: S
authors.lastname: Koren
mesh_terms: D000328:Adult; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001853:Bone Marrow / Q000473:pathology; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D051359:Lymphohistiocytosis, Hemophagocytic / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology; D008262:Macrophage Activation / Q000187:drug effects*; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept